Skip to main content
Screener/Healthcare/Biotechnology

BBOT — BridgeBio Oncology Therapeutics Inc.

NASDAQ
$2.00-0.17 (-8.06%)
$1.98
$14.87
$1.98
$2.25
EPS (TTM)$-5.71
P/E Ratio-2.04
Dividend Yield—
Market Cap$174.0M
Volume337K
Prev Close$2.17
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$42.1M$-1.35——
Q4 '25$0-$38.8M$-1.25——
Q3 '25$0-$44.8M$-1.90——
Q2 '25$0-$28.4M$-1.21——
Q1 '25$0-$22.1M$-0.94——
Q4 '24$0-$19.7M$0.12——
Q3 '24$0-$17.3M$-0.74——
Q2 '24$0-$21.8M$0.09——
Get Your Daily Market Recap